These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27618920)

  • 1. Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil.
    Machado de Assis TS; Azeredo-da-Silva AL; Werneck GL; Rabello A
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):464-71. PubMed ID: 27618920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil.
    Assis TSM; Azeredo-da-Silva ALF; Oliveira D; Cota G; Werneck GL; Rabello A
    Cad Saude Publica; 2017 Dec; 33(12):e00142416. PubMed ID: 29267689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.
    Freire ML; de Souza A; Cota G; Rabello A; Machado de Assis T
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008741. PubMed ID: 33031382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil.
    Assis TSM; Rabello A; Cota G; Werneck GL; Azeredo-da-Silva ALF
    Rev Soc Bras Med Trop; 2019 Apr; 52():e20180272. PubMed ID: 30994802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil.
    Machado de Assis TS; Rabello A; Werneck GL
    Trop Med Int Health; 2012 Oct; 17(10):1202-7. PubMed ID: 22897740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil.
    Assis TS; Guimarães PN; Oliveira E; Peruhype-Magalhães V; Gomes LI; Rabello A
    Cad Saude Publica; 2015 Oct; 31(10):2127-36. PubMed ID: 26735380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance and potential barriers to effective use of diagnostic tests for visceral leishmaniasis in an urban area in Brazil.
    Assis TM; Guimarães PN; Oliveira E; Peruhype-Magalhães V; Gomes LI; Rabello A
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):241-4. PubMed ID: 27192596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.
    Cañavate C; Herrero M; Nieto J; Cruz I; Chicharro C; Aparicio P; Mulugeta A; Argaw D; Blackstock AJ; Alvar J; Bern C
    Am J Trop Med Hyg; 2011 Jan; 84(1):102-6. PubMed ID: 21212210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis.
    Oliveira E; Saliba SW; Saliba JW; Rabello A
    Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):243-7. PubMed ID: 23382276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre evaluation of a direct agglutination test prototype kit (DAT-LPC) for diagnosis of visceral leishmaniasis.
    Oliveira E; Oliveira D; Cardoso FA; Barbosa JR; Marcelino AP; Dutra T; Araujo T; Fernandes L; Duque D; Rabello A
    Parasitology; 2017 Dec; 144(14):1964-1970. PubMed ID: 28735574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis.
    Freire ML; Machado de Assis T; Oliveira E; Moreira de Avelar D; Siqueira IC; Barral A; Rabello A; Cota G
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007484. PubMed ID: 31318856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis.
    Boelaert M; Rijal S; Regmi S; Singh R; Karki B; Jacquet D; Chappuis F; Campino L; Desjeux P; Le Ray D; Koirala S; Van der Stuyft P
    Am J Trop Med Hyg; 2004 Jan; 70(1):72-7. PubMed ID: 14971701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis.
    Pedras MJ; de Gouvêa Viana L; de Oliveira EJ; Rabello A
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):172-8. PubMed ID: 18160087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of visceral leishmaniasis care in Brazil.
    de Carvalho IPSF; Peixoto HM; Romero GAS; de Oliveira MRF
    Trop Med Int Health; 2017 Dec; 22(12):1579-1589. PubMed ID: 29078015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-centric prospective evaluation of rk39 rapid test and direct agglutination test for the diagnosis of visceral leishmaniasis in Brazil.
    de Assis TS; Braga AS; Pedras MJ; Oliveira E; Barral A; de Siqueira IC; Costa CH; Costa DL; Holanda TA; Soares VY; Biá M; Caldas Ade J; Romero GA; Rabello A
    Trans R Soc Trop Med Hyg; 2011 Feb; 105(2):81-5. PubMed ID: 20970152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda.
    Chappuis F; Mueller Y; Nguimfack A; Rwakimari JB; Couffignal S; Boelaert M; Cavailler P; Loutan L; Piola P
    J Clin Microbiol; 2005 Dec; 43(12):5973-7. PubMed ID: 16333084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Kala-Azar Detect® and IT-LEISH® rapid tests for the diagnosis of visceral leishmaniasis in Brazil.
    Peruhype-Magalhães V; Machado-de-Assis TS; Rabello A
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):951-2. PubMed ID: 23147155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.
    Boelaert M; Lynen L; Desjeux P; Van der Stuyft P
    Bull World Health Organ; 1999; 77(8):667-74. PubMed ID: 10516788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of visceral leishmaniasis diagnosis using indirect fluorescent antibody tests in 4 pediatric patients].
    Balcı YI; Türk M; Ozgür A; Küçüktaşçı K
    Turkiye Parazitol Derg; 2011; 35(2):114-6. PubMed ID: 21776599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of direct agglutination test (DAT) for laboratory diagnosis of visceral leishmaniasis in Brazil.
    Oliveira E; Pedras MJ; de Assis IE; Rabello A
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1279-81. PubMed ID: 19457530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.